Immunoglobulin F(ab')2 fragment (Shanghai Serum Bio)
马破伤风免疫球蛋白(F(ab’)2) （上海赛伦）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameImmunoglobulin F(ab')2 fragment (Shanghai Serum Bio)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1982/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Serum Bio-Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Serum Bio-Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A